Skip to main content
. 2008 Dec;138(12):2436–2441. doi: 10.3945/jn.108.097766

TABLE 2.

RR (95% CI) of CHD associated with plasma markers of body iron stores among U.S. women1

Quartile of body iron store biomarker
Biomarker2 1 (lowest) 2 3 4 (highest) P-trend3
sTfR:ferritin ratio
    Cases/control, n/n 48/120 75/121 57/121 62/121
    Mean (range) 0.01 (0.001–0.02) 0.02 (0.01–0.04) 0.04 (0.02–0.08) 0.17 (0.04–2.48)
    Model 1 (matching factors) 1.0 1.54 (0.99, 2.41) 1.19 (0.75, 1.90) 1.27 (0.80, 2.02) 0.95
    Model 2 (multivariate) 1.0 1.42 (0.89, 2.28) 1.14 (0.70, 1.86) 1.15 (0.70, 1.90) 0.72
    Model 3 (multivariate) 1.0 1.39 (0.82, 2.36) 1.12 (0.66, 1.91) 1.13 (0.65, 1.97) 0.61
Ferritin, μg/L
    Cases/control, n/n 57/120 53/119 70/123 62/121
    Mean (range) 21.1 (3.0–41.3) 49.8 (34.4–68.1) 90.5 (64.3–120.2) 189.4 (118.4–683.0)
    Model 1 (matching factors) 1.0 0.94 (0.60, 1.47) 1.19 (0.77, 1.84) 1.09 (0.69, 1.73) 0.58
    Model 2 (multivariate) 1.0 1.01 (0.63, 1.63) 1.21 (0.75, 1.94) 1.14 (0.69, 1.88) 0.55
    Model 3 (multivariate) 1.0 1.05 (0.62, 1.77) 1.19 (0.69, 2.03) 1.05 (0.60, 1.85) 0.90
sTfR, mg/L
    Cases/control, n/n 33/121 61/120 59/122 89/120
    Mean (range) 1.41 (0.53–2.37) 1.76 (1.21–2.86) 2.11 (1.44–3.39) 2.80 (1.73–7.45)
    Model 1 (matching factors) 1.0 1.94 (1.17, 3.21) 1.81 (1.10, 2.97) 2.79 (1.70, 4.59) 0.0004
    Model 2 (multivariate) 1.0 1.91 (1.11, 3.26) 1.56 (0.92, 2.63) 2.39 (1.40, 4.07) 0.01
    Model 3 (multivariate) 1.0 1.74 (0.98, 3.10) 1.40 (0.79, 2.47) 1.54 (0.85, 2.77) 0.36
1

The lowest quartile is the reference group. Mean (range) of each quartile is based on the distributions among controls.

2

Model 1 is controlled for matching factors, i.e. age at blood draw (y), smoking status (never, past, current), and fasting status (yes, no). Multivariate model 2 is further controlled for postmenopausal status (yes, no), postmenopausal hormone use (never, past, current), physical activity (in tertiles), alcohol intake (0, 0–4, 5–14, ≥15 g/d), intake of red meat (g/d), parental history of MI before age 65 y (yes, no), and BMI (<25, 25–29, ≥30 kg/m2). Based on model 2, model 3 is further adjusted for history of hypertension (presence, absence), history of hypercholesterolemia (presence, absence), and history of diabetes (presence, absence).

3

Linear scores derived from the medians of quartiles of biomarker levels among controls were used to estimate P-values for trend. Estimates of P-value for linear trend are all based on t tests.